Summit Therapeutics
SMMT
#2244
Rank
A$12.02 B
Marketcap
A$15.03
Share price
-5.87%
Change (1 day)
-40.03%
Change (1 year)

EPS for Summit Therapeutics (SMMT)

EPS in 2026 (TTM): A-$1.56

According to Summit Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$1.62. In 2025 the company made an earnings per share (EPS) of A-$2.19.

EPS history for Summit Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.56-28.83%
2025A-$2.19
2021A-$1.4526.32%
2020A-$1.15
2018A-$0.06557-84.63%
2017A-$0.43-40.59%
2016A-$0.726.54%
2015A-$0.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
A-$3.97 145.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
A$20.94-1,395.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
A-$1.56-3.74%๐Ÿ‡บ๐Ÿ‡ธ USA